Explorer
Will we get nod for vaccine's emergency use? DCGI press conference at 11 am
The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech's 'Covaxin' for emergency use in India. The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI).
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
DCGI will conduct a press conference today.
Notably, the panel recommended emergency licensure for the Serum Institute of India-manufactured 'Covishield'. It becomes the first vaccine to secure recommendation for emergency use in India. The nod of the DCGI is, however, awaited on the recommendation.
India
Patna: One Killed in Patna Road Accident, Violent Protest Erupts, Vehicles Set Ablaze
BREAKING: Patna Highway Erupts in Violence After Fatal Bus Accident, Vehicles Set Ablaze by Crowd
BREAKING: Rajya Sabha Adjourned Till Monday Amid Opposition Uproar, Lok Sabha Proceedings Continue
Rajya Sabha: Kiren Rijiju Defends Home Minister Amid Opposition Protest in Rajya Sabha
Student Protest: Student Protester Hospitalised After Health Deteriorates at Ranchi Agitation
View More
Top Headlines
Celebrities
‘Why Rahul Gandhi?’: Simi Garewal Reacts To Sonam Wangchuk’s Claim That Wife Tried To Get Him To End Fast
World
Africa CDC To Use Vaccine For Prior Zaire Ebola Strain As Stop-Gap Against DRC Outbreak
World
Houthi Attack Injures 11 In Saudi Arabia; Riyadh, Turkey And Pakistan Set For Defense Pact
World
Trump Signs New Orders To Restrict Birthright Citizenship, Targets Birth Tourism
Trending News
